106 related articles for article (PubMed ID: 23861901)
1. The polyphenol fisetin protects bone by repressing NF-κB and MKP-1-dependent signaling pathways in osteoclasts.
Léotoing L; Wauquier F; Guicheux J; Miot-Noirault E; Wittrant Y; Coxam V
PLoS One; 2013; 8(7):e68388. PubMed ID: 23861901
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of osteoblastic bone formation by nuclear factor-kappaB.
Chang J; Wang Z; Tang E; Fan Z; McCauley L; Franceschi R; Guan K; Krebsbach PH; Wang CY
Nat Med; 2009 Jun; 15(6):682-9. PubMed ID: 19448637
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone‑IIA attenuates the deleterious effects of oxidative stress in osteoporosis through the NF‑κB signaling pathway.
Zhu S; Wei W; Liu Z; Yang Y; Jia H
Mol Med Rep; 2018 May; 17(5):6969-6976. PubMed ID: 29568934
[TBL] [Abstract][Full Text] [Related]
4. Biological effects and mechanisms of fisetin in cancer: a promising anti-cancer agent.
Zhou C; Huang Y; Nie S; Zhou S; Gao X; Chen G
Eur J Med Res; 2023 Aug; 28(1):297. PubMed ID: 37626424
[TBL] [Abstract][Full Text] [Related]
5. Fisetin: An anticancer perspective.
Imran M; Saeed F; Gilani SA; Shariati MA; Imran A; Afzaal M; Atif M; Tufail T; Anjum FM
Food Sci Nutr; 2021 Jan; 9(1):3-16. PubMed ID: 33473265
[TBL] [Abstract][Full Text] [Related]
6. The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review.
Yu W; Zhao Y; Ilyas I; Wang L; Little PJ; Xu S
J Pharm Pharmacol; 2024 May; ():. PubMed ID: 38733634
[TBL] [Abstract][Full Text] [Related]
7. Fisetin is a senotherapeutic that extends health and lifespan.
Yousefzadeh MJ; Zhu Y; McGowan SJ; Angelini L; Fuhrmann-Stroissnigg H; Xu M; Ling YY; Melos KI; Pirtskhalava T; Inman CL; McGuckian C; Wade EA; Kato JI; Grassi D; Wentworth M; Burd CE; Arriaga EA; Ladiges WL; Tchkonia T; Kirkland JL; Robbins PD; Niedernhofer LJ
EBioMedicine; 2018 Oct; 36():18-28. PubMed ID: 30279143
[TBL] [Abstract][Full Text] [Related]
8. The flavonoid fisetin promotes osteoblasts differentiation through Runx2 transcriptional activity.
Léotoing L; Davicco MJ; Lebecque P; Wittrant Y; Coxam V
Mol Nutr Food Res; 2014 Jun; 58(6):1239-48. PubMed ID: 24535991
[TBL] [Abstract][Full Text] [Related]
9. Anti-osteoporosis Effect of Fisetin against Ovariectomy Induced Osteoporosis in Rats: In silico, in vitro and in vivo Activity.
Feng P; Shu S; Zhao F
J Oleo Sci; 2022; 71(1):105-118. PubMed ID: 35013033
[TBL] [Abstract][Full Text] [Related]
10. Targeted Reduction of Senescent Cell Burden Alleviates Focal Radiotherapy-Related Bone Loss.
Chandra A; Lagnado AB; Farr JN; Monroe DG; Park S; Hachfeld C; Tchkonia T; Kirkland JL; Khosla S; Passos JF; Pignolo RJ
J Bone Miner Res; 2020 Jun; 35(6):1119-1131. PubMed ID: 32023351
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents.
Rizzo MG; Best TM; Huard J; Philippon M; Hornicek F; Duan Z; Griswold AJ; Kaplan LD; Hare JM; Kouroupis D
Cells; 2023 May; 12(10):. PubMed ID: 37408255
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity.
Zhou J; Nie RC; Yin YX; Cai XX; Xie D; Cai MY
Dis Markers; 2022; 2022():1612348. PubMed ID: 36419843
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress.
Hassan SSU; Samanta S; Dash R; Karpiński TM; Habibi E; Sadiq A; Ahmadi A; Bunagu S
Front Pharmacol; 2022; 13():1015835. PubMed ID: 36299900
[TBL] [Abstract][Full Text] [Related]
14. Polyphenols: Bioavailability, Microbiome Interactions and Cellular Effects on Health in Humans and Animals.
Scott MB; Styring AK; McCullagh JSO
Pathogens; 2022 Jul; 11(7):. PubMed ID: 35890016
[TBL] [Abstract][Full Text] [Related]
15. Osteogenic Effect of Fisetin Doping in Bioactive Glass/Poly(caprolactone) Hybrid Scaffolds.
Granel H; Bossard C; Collignon AM; Wauquier F; Lesieur J; Rochefort GY; Jallot E; Lao J; Wittrant Y
ACS Omega; 2022 Jul; 7(26):22279-22290. PubMed ID: 35811886
[TBL] [Abstract][Full Text] [Related]
16. Fisetin: An Integrated Approach to Identify a Strategy Promoting Osteogenesis.
Dalle Carbonare L; Bertacco J; Gaglio SC; Minoia A; Cominacini M; Cheri S; Deiana M; Marchetto G; Bisognin A; Gandini A; Antoniazzi F; Perduca M; Mottes M; Valenti MT
Front Pharmacol; 2022; 13():890693. PubMed ID: 35652047
[TBL] [Abstract][Full Text] [Related]
17. Age Related Osteoporosis: Targeting Cellular Senescence.
Föger-Samwald U; Kerschan-Schindl K; Butylina M; Pietschmann P
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269841
[TBL] [Abstract][Full Text] [Related]
18. Geroprotectors and Skeletal Health: Beyond the Headlines.
Rayson A; Boudiffa M; Naveed M; Griffin J; Dall'Ara E; Bellantuono I
Front Cell Dev Biol; 2022; 10():682045. PubMed ID: 35223825
[TBL] [Abstract][Full Text] [Related]
19. Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways.
Huang XL; Liu C; Shi XM; Cheng YT; Zhou Q; Li JP; Liao J
Mol Med Rep; 2022 Feb; 25(2):. PubMed ID: 34935053
[TBL] [Abstract][Full Text] [Related]
20. The role of senolytics in osteoporosis and other skeletal pathologies.
Doolittle ML; Monroe DG; Farr JN; Khosla S
Mech Ageing Dev; 2021 Oct; 199():111565. PubMed ID: 34499959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
